This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Oncology

18
Cardio-oncology expert Dr Rebecca Dobson joins speaker line-up for HHE event
Cardio-oncology expert Dr Rebecca Dobson joins speaker line-up for HHE event
Read more
Evidence suggests self-sampling HPV tests could be a ‘game changer’
Evidence suggests self-sampling HPV tests could be a ‘game changer’
Read more
In conversation with consultant clinical oncologist Dr Petra Jankowska
In conversation with consultant clinical oncologist Dr Petra Jankowska
Read more
Escalating workforce crisis jeopardising cancer care and patient health, warns RCR
Escalating workforce crisis jeopardising cancer care and patient health, warns RCR
Read more
Driving efficiencies in breast cancer screening via AI with Dr Gerald Lip
Driving efficiencies in breast cancer screening via AI with Dr Gerald Lip
Read more
Dr Carlos Barrios on addressing disparities in breast cancer care
Dr Carlos Barrios on addressing disparities in breast cancer care
Read more
Experts champion risk-stratified approach to breast cancer screening
Experts champion risk-stratified approach to breast cancer screening
Read more
Access to tumour profiling tests for guiding adjuvant chemotherapy decisions expanded
Access to tumour profiling tests for guiding adjuvant chemotherapy decisions expanded
Read more
Taking the guess work out of cancer treatment with whole genome sequencing
Taking the guess work out of cancer treatment with whole genome sequencing
Read more
Unravelling the origins of second cancers in children with Dr Jaume Mora
Unravelling the origins of second cancers in children with Dr Jaume Mora
Read more
Biomarker and MRI-enhanced strategies comparable for prostate cancer screening, study finds
Biomarker and MRI-enhanced strategies comparable for prostate cancer screening, study finds
Read more
Tislelizumab approved by EC for three indications in NSCLC
Tislelizumab approved by EC for three indications in NSCLC
Read more
European approval for cilta-cel as second-line R/R multiple myeloma treatment
European approval for cilta-cel as second-line R/R multiple myeloma treatment
Read more
Patients ‘left behind’ due to inequalities in breast cancer care, report finds
Patients ‘left behind’ due to inequalities in breast cancer care, report finds
Read more
NICE recommends tisagenlecleucel for eligible patients with acute lymphoblastic leukaemia
NICE recommends tisagenlecleucel for eligible patients with acute lymphoblastic leukaemia
Read more
‘Dramatic decreases’ in cancer mortality in middle-aged people despite rising incidence
‘Dramatic decreases’ in cancer mortality in middle-aged people despite rising incidence
Read more
Deep learning tool outperforms current brain tumour diagnosis and classification methods
Deep learning tool outperforms current brain tumour diagnosis and classification methods
Read more
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer
Read more

Popular articles

Genetic link between pancreatitis risk and GLP-1 medicines to be investigated
Research, consensus and progress in fighting TB: ESCMID Global insights



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x